Oka, Tatsufumi
Sakaguchi, Yusuke
Isaka, Yoshitaka
Ishii, Haruka
Kabata, Daijiro
Shintani, Ayumi
Nakatani, Shinya
Morioka, Tomoaki
Mori, Katsuhito
Inaba, Masaaki
Emoto, Masanori
Shoji, Tetsuo
Funding for this research was provided by:
the Kidney Foundation, Japan
Article History
Received: 21 January 2022
Accepted: 5 September 2022
First Online: 14 September 2022
Competing interests
: T.O. has no disclosures. Y.S. received personal fees and research grant from Chugai Pharmaceutical, Kyowa Kirin, Bayer Yakuhin, Ono Pharmaceutical, Kissei Pharmaceutical, Torii Pharmaceutical, Mitsubishi Tanabe, and Fuso Pharmaceutical, outside the submitted work. Y.I. received grants and personal fees from Chugai Pharmaceutical, grants and personal fees from Kyowa Kirin, and personal fees from Kissei Pharmaceutical outside the submitted work. H.I. was employee of Kyowa Kirin. D.K. received personal fees from Chugai Pharmaceutical; research grant and consultation fee for statistical analysis from Kyowa Kirin; and personal fees and research grant from Bayer Yakuhin outside the submitted work. A.S. received personal fees from Chugai Pharmaceutical, Bayer Yakuhin, and Ono Pharmaceutical; and personal fees and research grants from Kyowa Kirin, Takeda Pharmaceutical, and Daiichi Sankyo outside the submitted work. S.N. received personal fees from Chugai Pharmaceutical, Kyowa Kirin, Bayer Yakuhin, Ono Pharmaceutical, Kissei Pharmaceutical, and Torii Pharmaceutical. T. M. received personal fees from Ono Pharmaceutical. K.M. received personal fees from Ono Pharmaceutical; he served as the principal investigator of a clinical trial for Kyowa Kirin; and personal fees and research grant from Mitsubishi Tanabe outside the submitted work. M.I. received personal fees from Chugai Pharmaceutical, Kyowa Kirin, Bayer Yakuhin, Ono Pharmaceutical, Kissei Pharmaceutical, and Torii Pharmaceutical outside the submitted work. M.E. received personal fees from Kissei Pharmaceutical, AstraZeneca, and Torii Pharmaceutical; and personal fees and research grants from Chugai Pharmaceutical, Kyowa Kirin, Ono Pharmaceutical, Nippon Boehringer Ingelheim, and Mitsubishi Tanabe outside the submitted work. T.S. received personal fees from Chugai Pharmaceutical, Kyowa Kirin, and Kissei Pharmaceutical; and personal fees and research grants from Bayer Yakuhin, and Ono Pharmaceutical outside the submitted work.